ASX:1AIPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Algorae Pharmaceuticals Ltd
$0.012
+$0.001 (+9.09%)
Day Range
$0.012 – $0.012
Volume
659.79K
Avg Volume (10D)
560.98K
Market Cap
$24.33M
Price Chart
OHLC · volume · moving averages
$0.012-$0.006 (-33.33%)over 6M
Hi$0.019Lo$0.010Avg Vol1.2M
Price-sensitive newsVolumePrev close · 52W rangeDrag the handles below to zoom
Market Statistics
Today's trading range
Open
$0.012
Previous Close
$0.011
Day High
$0.012
Day Low
$0.012
Valuation
Fundamental multiples
Market Cap
24.33M
Shares Outstanding
2.03B
Price to Book
9.83
Trading Activity
Volume & order book
Volume
659.79K
Value Traded
7.92K
Bid
$0.011 × 50,396
Ask
$0.012 × 1,490,379
Performance
Returns across timeframes
1 Day
0.00%
5 Day
0.00%
13 Week
-15.38%
52 Week
57.14%
YTD
-21.43%
— From the desk
Latest News
Biotechnology
Algorae Pharmaceuticals Expands AI Drug Combination Pipeline with Multi-Anchor AOS2 Program
Algorae expands AI drug-combo pipeline with AOS2: 18 anchors, 478k+ synergy predictions across cell lines; stock set for AI-driven discovery boost.
Biotechnology
Algorae Pharmaceuticals Enters Second Drug Synergy Screening Program with Peter MacCallum Cancer Centre
Algorae launches second AOS2 synergy program with Peter MacCallum Cancer Centre's VCFG; 24 drug combos across cancers; six-month preclinical data.
Biotechnology
Algorae Pharmaceuticals Partners with Cadila to Market Two New Medicines in Australia and NZ
Algorae inks Cadila deal to market two cardio/metabolic generics in Australia & NZ; Cadila develops/manufactures; AlgoraeRx handles regulatory and marketing.
Biotechnology
Algorae Pharmaceuticals Advances Commercial Pathway as AI Platform Validation and Distribution Agreements Gather Pace
Algorae Pharmaceuticals (ASX: 1AI) advances AlgoraeOS validation and signs Dr Reddy's distribution, signals near-term oncology revenue and stronger balance sheet.